Cognitive Function News and Research

RSS

Cognition is a concept used in different ways by different disciplines, but is generally accepted to mean the process of thought. For example, in psychology and cognitive science it refers to an information processing view of an individual's psychological functions.

RAZCER (Rapid Astrazeneca and CARO Evaluation of Radio-modifiers) awards announced - five Canadians win

Five leading Canadian radiation oncologists receive RAZCER Awards of $22,727 each for novel studies of radiation-drug interactions that have the potential to either protect normal tissues or sensitize tumours, and thus to enhance the effectiveness of radiation therapy for cancer patients. A selection committee of members of the Canadian Association of Radiation Oncology (CARO) selected the 2011 recipients from among a field of 12 applicants. Astrazeneca provides the funds for the RAZCER Award as an educational grant.

13 Oct 2011

Shield commences two ST10 Phase 3 studies in iron deficiency anaemia

Shield Therapeutics (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need, today announced that the first patients have been treated in the two Phase 3 clinical studies of ST10 for the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease.

12 Oct 2011

Measurable changes in brain function may be a consequence of early HIV infection

Measurable changes in brain function and communication between brain regions may be a consequence of virus-induced injury during the early stages of human immunodeficiency virus (HIV) infection.

7 Oct 2011

NICU stress linked with alterations in brain structure and function of preterm infants

New research shows that exposure to stressors in the Neonatal Intensive Care Unit (NICU) is associated with alterations in the brain structure and function of very preterm infants. According to the study now available in Annals of Neurology, a journal published by Wiley-Blackwell on behalf of the American Neurological Association and Child Neurology Society, infants who experienced early exposure to stress displayed decreased brain size, functional connectivity, and abnormal motor behavior.

4 Oct 2011

Tight blood sugar control fails to improve memory in diabetics

A new study has shown that those with type 2 diabetes do not show slowing of the decline in thinking skills with intense blood sugar control. In fact such intense therapy raises risk of death.

2 Oct 2011

Lifespan researcher receives Ig Nobel Prize at Harvard University

Peter J. Snyder, Ph.D., vice president of research for Lifespan, received one of 10 Ig Nobel Prize awards during the annual ceremony last night at Harvard University.

1 Oct 2011

Intensive blood glucose control therapy provides no added benefit against cognitive decline in older diabetics

Intensive control of blood sugar levels beyond standard targets provides no additional protection against cognitive decline in older people with diabetes than standard treatment, according to a national study coordinated by researchers at Wake Forest Baptist Medical Center.

29 Sep 2011

BioLineRx's BL-1020 Phase IIb EAGLE trial data on schizophrenia to be presented at ECSR

BioLineRx, a biopharmaceutical development company, today announced that data from the successfully completed Phase IIb EAGLE study of BL-1020, a first in class GABA-enhanced antipsychotic for the treatment of schizophrenia, will be presented at the 3rd European Conference on Schizophrenia Research (ECSR) held in Berlin, Germany.

28 Sep 2011

Low vitamin B12 raises risk of dementia in the elderly: Study

According to a latest study the elderly with low levels of vitamin B12 in their blood may be more likely to develop problems with their thinking skills and have more brain shrinkage. The study points to a link between low B12 and early cognitive decline, a condition that often leads to dementia. Previous research has found that those people with high levels of vitamin B12 in their blood have lower levels of an amino acid called homocysteine, which some studies have linked to an increased risk of Alzheimer's disease, memory loss, and stroke.

27 Sep 2011

Scientists find a way to rapidly produce pure populations of oligodendrocyte progenitor cells

Scientists at Case Western Reserve University School of Medicine found a way to rapidly produce pure populations of cells that grow into the protective myelin coating on nerves in mice. Their process opens a door to research and potential treatments for multiple sclerosis, cerebral palsy and other demyelinating diseases afflicting millions of people worldwide.

26 Sep 2011

Dementia patients have poor outcomes in hospital

If you have dementia and need to be admitted to hospital to be treated for other illnesses or injuries, your prospects for recovery are substantially worse than for other patients, research has found.

22 Sep 2011

Tackling Alzheimer’s and dementia

The latest research into the prevention and treatment of dementia and Alzheimer’s is the focus of a major conference in Sydney this week.

20 Sep 2011

Diabetes and dementia, connection found

A new study revealed that people with diabetes may be at an increased risk of developing dementia. Scientists have suspected the link between the two diseases for several years, but several experts say this latest study highlights how treating preventable diseases like diabetes and obesity may be useful in preventing the onset of dementia.

20 Sep 2011

Walnuts improve inferential reasoning skills among students

Recently published research in the September issue of British Journal of Nutrition suggests students may want to grab a handful of walnuts before taking that next exam. According to the study, students consuming walnuts improved their inferential reasoning skills - the ability to discover true from false.

20 Sep 2011

Giving up smoking can restore everyday memory

Giving up smoking isn't just good for your health, it's also good for your memory, according to research from Northumbria University.

20 Sep 2011

Humour as effective as medication in treating agitation in dementia, research shows

...

18 Sep 2011

Potential new treatment for fragile X syndrome

Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.

16 Sep 2011

Anavex Life Sciences to present data on lead compound for Alzheimer’s at Japan Neuroscience Society

Anavex Life Sciences Corp. will present the most recent data showing the therapeutic potential of ANAVEX compounds in animal models of Alzheimer’s disease at a special symposium of the 34th annual meeting of the Japan Neuroscience Society. The symposium is being held in Yokohama, Japan from September 15-17, 2011.

15 Sep 2011

International patient groups anxiously await start of Huntington’s trial

Prana Biotechnology Limited received a very positive reaction from international patient groups and researchers at this week’s World Congress on Huntington’s Disease in Melbourne. The company had a major presence at the Congress and the Prana team has held numerous meetings and conversations with patient groups and researchers.

15 Sep 2011

Alzheimer’s & You: prevention & treatment of dementia

Despite many promising leads, no drug has yet been found to slow or modify the debilitating, and ultimately fatal, progress of Alzheimer’s disease, the most common form of dementia. Within 20 years almost half a million Australians will suffer from dementia, by 2050 the number will double to one million.

15 Sep 2011

Cognitive Function News and Research

Further Reading

RAZCER (Rapid Astrazeneca and CARO Evaluation of Radio-modifiers) awards announced - five Canadians win

Shield commences two ST10 Phase 3 studies in iron deficiency anaemia

Measurable changes in brain function may be a consequence of early HIV infection

NICU stress linked with alterations in brain structure and function of preterm infants

Tight blood sugar control fails to improve memory in diabetics

Lifespan researcher receives Ig Nobel Prize at Harvard University

Intensive blood glucose control therapy provides no added benefit against cognitive decline in older diabetics

BioLineRx's BL-1020 Phase IIb EAGLE trial data on schizophrenia to be presented at ECSR

Low vitamin B12 raises risk of dementia in the elderly: Study

Scientists find a way to rapidly produce pure populations of oligodendrocyte progenitor cells

Dementia patients have poor outcomes in hospital

Tackling Alzheimer’s and dementia

Diabetes and dementia, connection found

Walnuts improve inferential reasoning skills among students

Giving up smoking can restore everyday memory

Humour as effective as medication in treating agitation in dementia, research shows

Potential new treatment for fragile X syndrome

Anavex Life Sciences to present data on lead compound for Alzheimer’s at Japan Neuroscience Society

International patient groups anxiously await start of Huntington’s trial

Alzheimer’s & You: prevention & treatment of dementia

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News